{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:50:26Z","timestamp":1773701426530,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-026-00896-1","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:21:57Z","timestamp":1773656517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OTUD5-related rare X-linked multiple congenital anomalies and neurodevelopmental syndrome: clinical findings and review of the literature"],"prefix":"10.1007","volume":"27","author":[{"given":"Arzu","family":"Ero\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilan Gen\u00e7","family":"Akda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl","family":"\u00dcnsel-Bolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alperen","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilmi","family":"Bolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"896_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","volume":"154","author":"TE Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N et al (2013) OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 154(1):169\u2013184. https:\/\/doi.org\/10.1016\/j.cell.2013.05.020","journal-title":"Cell"},{"issue":"4","key":"896_CR2","doi-asserted-by":"publisher","first-page":"eabe2116","DOI":"10.1126\/sciadv.abe2116","volume":"7","author":"DB Beck","year":"2021","unstructured":"Beck DB, Basar MA, Asmar AJ, Thompson JJ, Oda H, Uehara DT et al (2021) Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation. Sci Adv 7(4):eabe2116. https:\/\/doi.org\/10.1126\/sciadv.abe2116","journal-title":"Sci Adv"},{"issue":"7","key":"896_CR3","doi-asserted-by":"publisher","first-page":"2406700","DOI":"10.1002\/advs.202406700","volume":"12","author":"X Song","year":"2025","unstructured":"Song X, Liu T, Yu L, Ji Q, Guo X, Zong R, Liu H (2025) OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of \u03b1-Synuclein in a Parkinson\u2019s Disease Model. Adv Sci 12(7):2406700","journal-title":"Adv Sci"},{"issue":"2","key":"896_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/cge.13873","volume":"99","author":"K Tripolszki","year":"2021","unstructured":"Tripolszki K, Sasaki E, Hotakainen R, Virtanen A, Alitalo T, Tuupanen S et al (2021) An X-linked syndrome with severe neurodevelopmental delay, hydrocephalus, and early lethality caused by a missense variation in the OTUD5 gene. Clin Genet 99(2):303\u2013308. https:\/\/doi.org\/10.1111\/cge.13814","journal-title":"Clin Genet"},{"key":"896_CR5","unstructured":"Durkie M, Cassidy EJ, Berry I, Owens M, Turnbull C, Scott RH, McMullan14 DJ (2023) ACGS best practice guidelines for variant classification in rare"},{"issue":"11","key":"896_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41431-023-01324-w","volume":"31","author":"C Giovenino","year":"2023","unstructured":"Giovenino C, Trajkova S, Pavinato L, Cardaropoli S, Pullano V, Ferrero E, Brusco A (2023) Skewed X-chromosome inactivation in unsolved neurodevelopmental disease cases can guide re-evaluation for X-linked genes. Eur J Hum Genet 31(11):1228\u20131236","journal-title":"Eur J Hum Genet"},{"key":"896_CR7","doi-asserted-by":"publisher","first-page":"631428","DOI":"10.3389\/fcell.2021.631428","volume":"9","author":"K Saida","year":"2021","unstructured":"Saida K, Fukuda T, Scott DA, Walsh T, Tanaka Y, Sasaki E et al (2021) OTUD5 variants associated with X-linked intellectual disability and congenital malformation. Front Cell Dev Biol 9:631428. https:\/\/doi.org\/10.3389\/fcell.2021.631428","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"896_CR8","doi-asserted-by":"publisher","first-page":"e2325","DOI":"10.1002\/mgg3.2325","volume":"11","author":"W Tian","year":"2023","unstructured":"Tian W, Li H, Li Y, Liang D, Tian X, Li H et al (2023) A novel missense variant in OTUD5 causes X-linked multiple congenital anomalies-neurodevelopmental syndrome. Mol Genet Genomic Med 11(6):e2325. https:\/\/doi.org\/10.1002\/mgg3.2325","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"896_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"3","key":"896_CR10","doi-asserted-by":"publisher","first-page":"107456","DOI":"10.1016\/j.celrep.2020.107456","volume":"31","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yang C, Wu R, Li Y, Liu Z, Yuan X et al (2020) OTUD5 impairs innate immunity by deubiquitinating and stabilizing the replication protein A1 (RPA1). Cell Rep 31(3):107456. https:\/\/doi.org\/10.1016\/j.celrep.2020.107456","journal-title":"Cell Rep"},{"issue":"3","key":"896_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41418-020-00649-z","volume":"28","author":"J Cho","year":"2021","unstructured":"Cho J, Kim K, Kim SA, Kim JY, Park JJ, Kang HG et al (2021) Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways. Cell Death Differ 28(3):900\u2013914. https:\/\/doi.org\/10.1038\/s41418-020-00645-1","journal-title":"Cell Death Differ"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1038\/s41467-020-17926-7","volume":"11","author":"F Li","year":"2020","unstructured":"Li F, Sun Q, Liu K, Tang Y, Wang M, Xie L et al (2020) OTUD5 collaborates with TRIM25 in transcriptional regulation and tumor progression through its deubiquitination activity. Nat Commun 11:3356. https:\/\/doi.org\/10.1038\/s41467-020-17926-7","journal-title":"Nat Commun"},{"issue":"8","key":"896_CR13","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s41423-020-00531-5","volume":"18","author":"Y Guo","year":"2021","unstructured":"Guo Y, Jiang F, Kong L, Wu H, Zhang H, Chen X, Gao C (2021) OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING. Cell Mol Immunol 18(8):1945\u20131955","journal-title":"Cell Mol Immunol"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-026-00896-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-026-00896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:02:33Z","timestamp":1773698553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-026-00896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s10048-026-00896-1","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Bal\u0131kesir Atat\u00fcrk City Hospital Ethics Committee on October 23, 2025 (Decision No: 2025\/10\/20). Written informed consent was obtained from the patient\u2019s legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure\/Conflict of Interest"}}],"article-number":"23"}}